These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6396835)

  • 21. Liposomes, muramyl dipeptide derivatives, and nontoxic lipid A derivatives as adjuvants for human malaria vaccines.
    Hui GS
    Am J Trop Med Hyg; 1994; 50(4 Suppl):41-51. PubMed ID: 8172331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An effective immunization of experimental monkeys against a human malaria parasite, Plasmodium falciparum.
    Siddiqui WA
    Science; 1977 Jul; 197(4301):388-9. PubMed ID: 406671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of a synthetic Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice.
    Moreno CA; Rodriguez R; Oliveira GA; Ferreira V; Nussenzweig RS; Moya Castro ZR; Calvo-Calle JM; Nardin E
    Vaccine; 1999 Aug; 18(1-2):89-99. PubMed ID: 10501239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relevance of the guinea-pig necrotic inflammation footpad reaction to safety concerns with MDP-based adjuvants.
    Hjorth RN; Bonde GM; Piner ED; Goldberg KM; Levner MH; Hung PP
    Vaccine; 1994 Jun; 12(8):687-90. PubMed ID: 8091845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
    Lew AM; Anders RF; Edwards SJ; Langford CJ
    Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination of rhesus monkeys against Plasmodium knowlesi with aqueous suspension of MDP as an adjuvant.
    Khanna R; Ahmad S; Khan HM; Kumar H; Mahdi AA
    Indian J Malariol; 1991 Jun; 28(2):99-104. PubMed ID: 1810753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nor-MDP, saponin, corynebacteria, and pertussis organisms as immunological adjuvants in experimental malaria vaccination of macaques.
    Mitchell GH; Richards WH; Voller A; Dietrich FM; Dukor P
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):189-97. PubMed ID: 232428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
    Yoo YC; Saiki I; Sato K; Azuma I
    Vaccine; 1992; 10(11):792-7. PubMed ID: 1441733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium falciparum: protein antigens identified by analysis of serum samples from vaccinated Aotus monkeys.
    Kan SC; Yamaga KM; Kramer KJ; Case SE; Siddiqui WA
    Infect Immun; 1984 Jan; 43(1):276-82. PubMed ID: 6360901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen.
    Tamura M; Yoo YC; Yoshimatsu K; Yoshida R; Oka T; Ohkuma K; Arikawa J; Azuma I
    Vaccine; 1995 Jan; 13(1):77-82. PubMed ID: 7762283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.
    Stowers AW; Chen Lh LH; Zhang Y; Kennedy MC; Zou L; Lambert L; Rice TJ; Kaslow DC; Saul A; Long CA; Meade H; Miller LH
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):339-44. PubMed ID: 11752405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a synthetic adjuvant for inducing anti-tumour immunity.
    Kataoka T; Kinomoto M; Takegawa M; Tokunaga T
    Vaccine; 1991 May; 9(5):300-2. PubMed ID: 1872013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
    Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
    J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382).
    Kaji M; Kaji Y; Kaji M; Ohkuma K; Honda T; Oka T; Sakoh M; Nakamura S; Kurachi K; Sentoku M
    Vaccine; 1992; 10(10):663-7. PubMed ID: 1523876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA; Maris DC; Doolan D; Charoenvit Y; Obaldia N; Rossan R; Sedegah M; Wang R; Hobart P; Margalith M; Hoffman S
    Vaccine; 1997 Jun; 15(8):913-5. PubMed ID: 9234546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.
    Giraldo MA; Arevalo-Pinzon G; Rojas-Caraballo J; Mongui A; Rodriguez R; Patarroyo MA
    Vaccine; 2009 Dec; 28(1):7-13. PubMed ID: 19782110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant.
    Mitsuzawa E; Yasuda T; Tamura N; Ohtani S
    Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.
    Jones TR; Narum DL; Gozalo AS; Aguiar J; Fuhrmann SR; Liang H; Haynes JD; Moch JK; Lucas C; Luu T; Magill AJ; Hoffman SL; Sim BK
    J Infect Dis; 2001 Jan; 183(2):303-312. PubMed ID: 11110648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.